Avalon GloboCare Corp.(ALBT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $1.6M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ALBT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Avalon GloboCare Corp. (ALBT), a Technology sector company. ALBT is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $1.6m in revenue. Based on the latest XBRL financial filings (Q1 2026), Avalon GloboCare Corp. reports net income of $-4.5M, free cash flow of $-2.9M. Top institutional holders of ALBT by reported 13-F value include Equitable Holdings,, GEODE CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ALBT trades on the Nasdaq exchange and files with the SEC under CIK 1630212. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALBT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Avalon GloboCare Corp. directly from SEC EDGAR.
Net Income
Q1 2026
$-4.5M
Free Cash Flow
Q1 2026
$-2.9M
Get alerted when ALBT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Avalon GloboCare Corp. including:
Top Institutional Holders of ALBT
Equitable Holdings, Inc.
$72.0K60,000 shGEODE CAPITAL MANAGEMENT, LLC
$32.9K61,949 shVANGUARD CAPITAL MANAGEMENT LLC
$30.4K57,325 shCITADEL ADVISORS LLC
$29.8K56,184 shScientech Research LLC
$21.4K40,374 shMORGAN STANLEY
$14.7K27,604 shStoneX Group Inc.
$10.6K20,000 shVANGUARD FIDUCIARY TRUST CO
$9.8K18,394 shProcyon Advisors, LLC
$9.5K17,825 shXTX Topco Ltd
$9.2K17,319 sh
| Fund | Value | Shares |
|---|---|---|
| Equitable Holdings, Inc. | $72.0K | 60,000 |
| GEODE CAPITAL MANAGEMENT, LLC | $32.9K | 61,949 |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.4K | 57,325 |
| CITADEL ADVISORS LLC | $29.8K | 56,184 |
| Scientech Research LLC | $21.4K | 40,374 |
| MORGAN STANLEY | $14.7K | 27,604 |
| StoneX Group Inc. | $10.6K | 20,000 |
| VANGUARD FIDUCIARY TRUST CO | $9.8K | 18,394 |
| Procyon Advisors, LLC | $9.5K | 17,825 |
| XTX Topco Ltd | $9.2K | 17,319 |
More Technology Companies
View all Technology →Put ALBT on your watchlist
Track score changes the day Avalon GloboCare Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ALBT a good stock to buy?
13F Pro's AI-powered analysis of Avalon GloboCare Corp. (ALBT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALBT are available on the ALBT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ALBT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALBT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Avalon GloboCare Corp.'s investment landscape.